107 related articles for article (PubMed ID: 7588320)
1. The mineralocorticoid activity of progesterone derivatives depends on the nature of the C18 substituent.
Souque A; Fagart J; Couette B; Davioud E; Sobrio F; Marquet A; Rafestin-Oblin ME
Endocrinology; 1995 Dec; 136(12):5651-8. PubMed ID: 7588320
[TBL] [Abstract][Full Text] [Related]
2. Renal action of progesterone and 18-substituted derivatives.
Rafestin-Oblin ME; Couette B; Barlet-Bas C; Cheval L; Viger A; Doucet A
Am J Physiol; 1991 Jun; 260(6 Pt 2):F828-32. PubMed ID: 1647687
[TBL] [Abstract][Full Text] [Related]
3. Photoaffinity labelling of the human mineralocorticoid receptor with steroids having a reactive group at position 3, 18 or 21.
Fagart J; Couette B; Souque A; Davioud E; Marquet A; Rafestin-Oblin ME
Biochim Biophys Acta; 1998 Oct; 1388(1):35-44. PubMed ID: 9774704
[TBL] [Abstract][Full Text] [Related]
4. New steroidal diazo ketones as potential photoaffinity labeling reagents for the mineralocorticoid receptor: synthesis and biological activities.
Davioud E; Fagart J; Souque A; Rafestin-Oblin ME; Marquet A
J Med Chem; 1996 Jul; 39(14):2860-4. PubMed ID: 8709117
[TBL] [Abstract][Full Text] [Related]
5. Cysteines 849 and 942 of human mineralocorticoid receptor are crucial for steroid binding.
Lupo B; Mesnier D; Auzou G
Biochemistry; 1998 Sep; 37(35):12153-9. PubMed ID: 9724527
[TBL] [Abstract][Full Text] [Related]
6. Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor.
Quinkler M; Meyer B; Bumke-Vogt C; Grossmann C; Gruber U; Oelkers W; Diederich S; Bahr V
Eur J Endocrinol; 2002 Jun; 146(6):789-99. PubMed ID: 12039699
[TBL] [Abstract][Full Text] [Related]
7. A single amino acid mutation of ala-773 in the mineralocorticoid receptor confers agonist properties to 11beta-substituted spirolactones.
Auzou G; Fagart J; Souque A; Hellal-Lévy C; Wurtz JM; Moras D; Rafestin-Oblin ME
Mol Pharmacol; 2000 Oct; 58(4):684-91. PubMed ID: 10999937
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the human mineralocorticoid receptor gene 5'-regulatory region: evidence for differential hormonal regulation of two alternative promoters via nonclassical mechanisms.
Zennaro MC; Le Menuet D; Lombès M
Mol Endocrinol; 1996 Dec; 10(12):1549-60. PubMed ID: 8961265
[TBL] [Abstract][Full Text] [Related]
9. 11beta-hydroxyprogesterone acts as a mineralocorticoid agonist in stimulating Na+ absorption in mammalian principal cortical collecting duct cells.
Rafestin-Oblin ME; Fagart J; Souque A; Seguin C; Bens M; Vandewalle A
Mol Pharmacol; 2002 Dec; 62(6):1306-13. PubMed ID: 12435797
[TBL] [Abstract][Full Text] [Related]
10. Molecular determinants of the recognition of ulipristal acetate by oxo-steroid receptors.
Petit-Topin I; Fay M; Resche-Rigon M; Ulmann A; Gainer E; Rafestin-Oblin ME; Fagart J
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():427-35. PubMed ID: 25204619
[TBL] [Abstract][Full Text] [Related]
11. Evolution of hormone selectivity in glucocorticoid and mineralocorticoid receptors.
Baker ME; Funder JW; Kattoula SR
J Steroid Biochem Mol Biol; 2013 Sep; 137():57-70. PubMed ID: 23907018
[TBL] [Abstract][Full Text] [Related]
12. Differential intracellular localization of human mineralocorticosteroid receptor on binding of agonists and antagonists.
Lombès M; Binart N; Delahaye F; Baulieu EE; Rafestin-Oblin ME
Biochem J; 1994 Aug; 302 ( Pt 1)(Pt 1):191-7. PubMed ID: 8068005
[TBL] [Abstract][Full Text] [Related]
13. Overexpression and characterization of the human mineralocorticoid receptor.
Alnemri ES; Maksymowych AB; Robertson NM; Litwack G
J Biol Chem; 1991 Sep; 266(27):18072-81. PubMed ID: 1655735
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic aspects of mineralocorticoid receptor activation.
Hellal-Levy C; Fagart J; Souque A; Rafestin-Oblin ME
Kidney Int; 2000 Apr; 57(4):1250-5. PubMed ID: 10760050
[TBL] [Abstract][Full Text] [Related]
15. 19-Nor progesterone is a mineralocorticoid agonist.
Funder JW; Adam WR
Endocrinology; 1981 Jul; 109(1):313-5. PubMed ID: 6263590
[TBL] [Abstract][Full Text] [Related]
16. Progestogens with antimineralocorticoid activity.
Losert W; Casals-Stenzel J; Buse M
Arzneimittelforschung; 1985; 35(2):459-71. PubMed ID: 4039568
[TBL] [Abstract][Full Text] [Related]
17. LLC-PK1 cells model 11 beta-hydroxysteroid dehydrogenase type 2 regulation of glucocorticoid access to renal mineralocorticoid receptors.
Leckie C; Chapman KE; Edwards CR; Seckl JR
Endocrinology; 1995 Dec; 136(12):5561-9. PubMed ID: 7588309
[TBL] [Abstract][Full Text] [Related]
18. The mineralocorticoid receptor discriminates aldosterone from glucocorticoids independently of the 11 beta-hydroxysteroid dehydrogenase.
Lombes M; Kenouch S; Souque A; Farman N; Rafestin-Oblin ME
Endocrinology; 1994 Sep; 135(3):834-40. PubMed ID: 8070376
[TBL] [Abstract][Full Text] [Related]
19. Sulfhydryl groups are involved in the binding of agonists and antagonists to the human mineralocorticoid receptor.
Souque A; Fagart J; Couette B; Rafestin-Oblin ME
J Steroid Biochem Mol Biol; 1996 Mar; 57(5-6):315-21. PubMed ID: 8639467
[TBL] [Abstract][Full Text] [Related]
20. Difference of in vivo and in vitro antimineralocorticoid potency of progesterone.
Quinkler M; Diederich S
Endocr Res; 2002 Nov; 28(4):465-70. PubMed ID: 12530650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
